| For: | Meier JJ, Nauck MA, Kask B, Holst JJ, Deacon CF, Schmidt WE, Gallwitz B. Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls. World J Gastroenterol 2006; 12(12): 1874-1880 [PMID: 16609993 DOI: 10.3748/wjg.v12.i12.1874] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i12/1874.htm |
| Number | Citing Articles |
| 1 |
William L. Hasler, Radoslav Coleski, William D. Chey, Kenneth L. Koch, Richard W. McCallum, John M. Wo, Braden Kuo, Michael D. Sitrin, Leonard A. Katz, Judy Hwang, John R. Semler, Henry P. Parkman. Differences in intragastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of gastric retention. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 294(6) doi: 10.1152/ajpgi.00023.2008
|
| 2 |
Christopher H.S. McIntosh, Scott Widenmaier, Su‐Jin Kim. Insulin and IGFs. Vitamins & Hormones 2009; 80 doi: 10.1016/S0083-6729(08)00615-8
|
| 3 |
E. Broide, O. Bloch, G. Ben-Yehudah, D. Cantrell, H. Shirin, M. J. Rapoport. Reduced GLP-1R Expression in Gastric Glands of Patients With Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 2014; 99(9) doi: 10.1210/jc.2014-1114
|
| 4 |
Mads M. Helsted, Nina L. Schaltz, Lærke S. Gasbjerg, Mikkel B. Christensen, Tina Vilsbøll, Filip K. Knop. Safety of native glucose-dependent insulinotropic polypeptide in humans. Peptides 2024; 177 doi: 10.1016/j.peptides.2024.171214
|
| 5 |
Matthias Banasch, Kerem Bulut, Dirk Hagemann, Henning Schrader, Jens J. Holst, Wolfgang E. Schmidt, Juris J. Meier. Glucagon-like peptide 2 inhibits ghrelin secretion in humans. Regulatory Peptides 2006; 137(3) doi: 10.1016/j.regpep.2006.07.009
|
| 6 |
R. Promberger, M. Gadenstätter, R. Ciovica, G. Schwab, C. Neumayer. Gastroesophageal reflux disease in diabetic patients: a systematic review. European Surgery 2007; 39(6) doi: 10.1007/s10353-007-0366-9
|
| 7 |
Michael A. Nauck, Juris J. Meier. Pancreatic Beta Cell in Health and Disease. 2008; doi: 10.1007/978-4-431-75452-7_17
|
| 8 |
Daniel R. Quast, Nina Schenker, Björn A. Menge, Michael A. Nauck, Christoph Kapitza, Juris J. Meier. Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes. Diabetes Care 2020; 43(9) doi: 10.2337/dc20-0720
|